Literature DB >> 8978258

Adverse events associated with mefloquine. Risk-benefit ratio must be taken into account.

S Dollow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8978258      PMCID： PMC2353025          DOI： 10.1136/bmj.313.7071.1553a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers.

Authors:  P J Barrett; P D Emmins; P D Clarke; D J Bradley
Journal:  BMJ       Date:  1996-08-31

2.  Neuropsychiatric reactions with mefloquine chemoprophylaxis.

Authors:  A M Croft; M J World
Journal:  Lancet       Date:  1996-02-03       Impact factor: 79.321

3.  Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa.

Authors:  R Steffen; E Fuchs; J Schildknecht; U Naef; M Funk; P Schlagenhauf; P Phillips-Howard; C Nevill; D Stürchler
Journal:  Lancet       Date:  1993-05-22       Impact factor: 79.321

4.  Long-term malaria prophylaxis with weekly mefloquine.

Authors:  H O Lobel; M Miani; T Eng; K W Bernard; A W Hightower; C C Campbell
Journal:  Lancet       Date:  1993-04-03       Impact factor: 79.321
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.